MTOR and malignant colon neoplasm: As mentioned above, in colon cancer, SNX10 has been proved to regulate expression of a core effector, P21, in tumor suppressing pathways and to affect metabolism of amino acids mediating activation of mTOR by regulating chaperone-mediated autophagy.